Lisa Newman

Oct 1, 2024 | acsjournals.onlinelibrary.wiley.com | Angela N. Giaquinto |Hyuna Sung |Lisa Newman |Rachel A. Freedman

INTRODUCTION Despite decades of declining mortality through earlier detection and advancements in treatment, breast cancer remains the second leading cause of cancer death among women overall and the leading cause of cancer death in Black and Hispanic women. Continued progress may be thwarted by rising breast cancer incidence and long-term consequences of the coronavirus disease 2019 (COVID-19) pandemic, such as delayed diagnosis because of interruptions in routine care.

Sep 25, 2024 | jamanetwork.com | Lisa Newman

Importance of Cooperation Between Cooperative Group Clinical Trialists No clinical trial is conducted in a vacuum. Over the several years that are necessary to complete accrual and follow-up, various trials are reaching maturity and their collective results will influence both interpretation and implementation patterns.

May 31, 2024 | mdpi.com | Antonia Syrnioti |Stamatios Petousis |Lisa Newman |Chrysoula Margioula-Siarkou

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

May 21, 2024 | healio.com | Jennifer Southall |Mindy Valcarcel |Lori J. Pierce |Lisa Newman

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Several women oncologists will be honored during this year’s ASCO Annual Meeting. ASCO’s special awards recognize clinicians and scientists who have globally reshaped cancer care. Lori J.

Mar 27, 2024 | jamanetwork.com | Lisa Newman |Kuala Lumpur |Emily Shippee Rockefeller

Safety of Pregnancy After Breast Cancer in BRCA Mutation Carriers Lambertini et al1 have contributed important data regarding the safety of pregnancy following treatment for BRCA mutation–associated breast cancer. With nearly 8 years median follow-up involving 4732 patients and 659 pregnancies (20.8% with assisted reproductive technology), they found no adverse effects of pregnancy on survival outcomes.